WorksheetsDDD Recitation
Total questions: 20
Worksheet time: 7mins
First stage in discovery phase
choosing a target
choosing a disease
choosing a bioassay
finding the lead compound
A key molecule that is involved in a particular metabolic or signaling pathway that is specific to disease
Receptor
Chemical messenger
Enzyme
Nucleic acid
The central driving force for new drug discovery today
Genomics
Biopharmaceutics
Serendipity
Choosing a disease
Drugs activity is tested on isolated tissues, cells or enzymes
In vitro
In vivo
In silico
Ex vivo
Bioassay which induces a clinical condition and treated with the test drug
In vivo
In vitro
In silico
Ex vivo
A compound showing a desired pharmacological property which can be used to initiate a medicinal chemistry project
Lead compound
Prototype compound
Prodrug
Investigational drug
Source of estrogen and progesterone
Dioscorea
Periwinkle
Serpentina
Cinchona
Used as a hypotensive agent and tranquilizer
Reserpine
Morphine
Vincristine
Quinine
Animal source of estrogen
pregnant mare
pigs
cows
cattle
Capable of examining 15,000 chemical compounds a week using 10 – 20 bioassay
High throughput screening
NMR
Mass spectroscopy
Computer-aided design
Use to determine structure of compounds, except
NMR
X-ray crystallography
LC-MS
High throughput screening
Atoms and functional groups required for a specific pharmacological activity, and their relative positions in space
Prodrug
Pharmacophore
Lead compound
Investigational compound
The study of the interaction of drugs with cells
Pharmacokinetics
Pharmacodynamics
Pharmaceutics
Pharmacology
The science of the properties of the drugs and its effects in the body
Pharmacology
Pharmaceutics
Toxicology
Pharmacodynamics
The handling of a drug within the body, it includes the ADME processes
Pharmacokinetics
Pharmacology
Toxicology
Pharmaceutics
Filed before drug may be given to human (clinical trials)
INDA
NDA
ANDA
SNDA
These studies also evaluate drug metabolism, structure-activity relationships, and the mechanism of action in humans.
Phase 1
Phase 2
Phase 3
Phase 4
This phase of testing also helps determine the common short-term side effects and risks associated with the drug.
Phase 1
Phase 2
Phase 3
Phase 4
These studies are intended to gather the additional information about effectiveness and safety that is needed to evaluate the overall benefit-risk relationship of the drug.
Phase 3
Phase 1
Phase 2
Phase 4
It is submitted for review and approval after the completion of the clinical trials and requirements have been met.
NDA
INDA
SNDA
ANDA
